These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 25801914

  • 1. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI, You X, Kong G, Ranheim EA, Wang J, Du J, Liu Y, Zhou Y, Ryu MJ, Zhang J.
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [Abstract] [Full Text] [Related]

  • 2. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
    Melo-Cardenas J, Xu Y, Wei J, Tan C, Kong S, Gao B, Montauti E, Kirsammer G, Licht JD, Yu J, Ji P, Crispino JD, Fang D.
    Blood; 2018 Jul 26; 132(4):423-434. PubMed ID: 29844011
    [Abstract] [Full Text] [Related]

  • 3. NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.
    Aydin E, Hallner A, Grauers Wiktorin H, Staffas A, Hellstrand K, Martner A.
    Oncogene; 2019 Feb 26; 38(9):1534-1543. PubMed ID: 30323311
    [Abstract] [Full Text] [Related]

  • 4. Dose-dependent effects of Dnmt3a in an inducible murine model of KrasG12D-driven leukemia.
    Rogers JH, Rosen A, Reyes JM, Ketkar S, Conneely SE, Gupta R, Yang L, Miller MB, Medrano G, Aguilar R, Uchenda N, Goodell MA, Rau RE.
    Exp Hematol; 2024 Jul 26; 135():104248. PubMed ID: 38834136
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
    Zhang J, Wang J, Liu Y, Sidik H, Young KH, Lodish HF, Fleming MD.
    Blood; 2009 Feb 05; 113(6):1304-14. PubMed ID: 19066392
    [Abstract] [Full Text] [Related]

  • 6. Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
    Dovey OM, Cooper JL, Mupo A, Grove CS, Lynn C, Conte N, Andrews RM, Pacharne S, Tzelepis K, Vijayabaskar MS, Green P, Rad R, Arends M, Wright P, Yusa K, Bradley A, Varela I, Vassiliou GS.
    Blood; 2017 Oct 26; 130(17):1911-1922. PubMed ID: 28835438
    [Abstract] [Full Text] [Related]

  • 7. Dnmt3a haploinsufficiency cooperates with oncogenic Kras to promote an early-onset T-cell acute lymphoblastic leukemia.
    Chang YI, Kong G, Ranheim EA, Tu PS, Yu YS, Zhang J.
    Am J Transl Res; 2017 Oct 26; 9(3):1326-1334. PubMed ID: 28386358
    [Abstract] [Full Text] [Related]

  • 8. Oncogenic Kras initiates leukemia in hematopoietic stem cells.
    Sabnis AJ, Cheung LS, Dail M, Kang HC, Santaguida M, Hermiston ML, Passegué E, Shannon K, Braun BS.
    PLoS Biol; 2009 Mar 17; 7(3):e59. PubMed ID: 19296721
    [Abstract] [Full Text] [Related]

  • 9. Unique dependence on Sos1 in Kras G12D -induced leukemogenesis.
    You X, Kong G, Ranheim EA, Yang D, Zhou Y, Zhang J.
    Blood; 2018 Dec 13; 132(24):2575-2579. PubMed ID: 30377195
    [Abstract] [Full Text] [Related]

  • 10. Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus.
    Li Q, Haigis KM, McDaniel A, Harding-Theobald E, Kogan SC, Akagi K, Wong JC, Braun BS, Wolff L, Jacks T, Shannon K.
    Blood; 2011 Feb 10; 117(6):2022-32. PubMed ID: 21163920
    [Abstract] [Full Text] [Related]

  • 11. KRAS (G12D) cooperates with AML1/ETO to initiate a mouse model mimicking human acute myeloid leukemia.
    Zhao S, Zhang Y, Sha K, Tang Q, Yang X, Yu C, Liu Z, Sun W, Cai L, Xu C, Cui S.
    Cell Physiol Biochem; 2014 Feb 10; 33(1):78-87. PubMed ID: 24480914
    [Abstract] [Full Text] [Related]

  • 12. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
    Shi X, Yang Y, Shang S, Wu S, Zhang W, Peng L, Huang T, Zhang R, Ren R, Mi J, Wang Y.
    BMC Cancer; 2019 Nov 08; 19(1):1072. PubMed ID: 31703632
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of β Common Receptor Moderately Attenuates the Progression of Myeloproliferative Neoplasm in NrasG12D/+ Mice.
    Zhang J, Ranheim EA, Du J, Liu Y, Wang J, Kong G, Zhang J.
    J Biol Chem; 2015 Jul 31; 290(31):19093-103. PubMed ID: 26082490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm.
    Kong G, You X, Wen Z, Chang YI, Qian S, Ranheim EA, Letson C, Zhang X, Zhou Y, Liu Y, Rajagopalan A, Zhang J, Stieglitz E, Loh M, Hofmann I, Yang D, Zhong X, Padron E, Zhou L, Pear WS, Zhang J.
    Leukemia; 2019 Mar 31; 33(3):671-685. PubMed ID: 30206308
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.
    Jin X, Qin T, Zhao M, Bailey N, Liu L, Yang K, Ng V, Higashimoto T, Coolon R, Ney G, Figueroa ME, Li Q.
    Blood Adv; 2018 Jun 12; 2(11):1259-1271. PubMed ID: 29866713
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.